Plunkett Research Online: Cancer Genetics Inc

CANCER GENETICS INC (CGIX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cancer Genetics, Inc. is a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment (theranosis) of cancer. The Company’s tests target cancers that are difficult to prognose and predict treatme.....



Cancer Genetics Inc
Ticker: CGIX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 201 528-9200
Fax:
Address: 201 Route 17 North
2nd Floor
Rutherford, NJ 07070 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Research and Development in Biotechnology
ContactsDescription
John PappajohnChairman of the Board/Director
Igor GitelmanChief Accounting Officer
See More
Cancer Genetics, Inc. is a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment (theranosis) of cancer. The Company’s tests target cancers that are difficult to prognose and predict treatme.....See More See More

Auditor: RSM US LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: